Northwest Biotherapeutics, Inc. NBYB.SG Stock
Northwest Biotherapeutics, Inc. Price Chart
Northwest Biotherapeutics, Inc. NBYB.SG Financial and Trading Overview
| Northwest Biotherapeutics, Inc. stock price | 0.44 EUR |
| Previous Close | 0.57 EUR |
| Open | 0.56 EUR |
| Bid | 0.58 EUR x 500000 |
| Ask | 0.62 EUR x 500000 |
| Day's Range | 0.56 - 0.56 EUR |
| 52 Week Range | 0.42 - 1.26 EUR |
| Volume | 0 EUR |
| Avg. Volume | 2.05K EUR |
| Market Cap | 645.24M EUR |
| Beta (5Y Monthly) | -0.129225 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NBYB.SG Valuation Measures
| Enterprise Value | 793.36M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 298.72113 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 367.298 |
| Enterprise Value/EBITDA | -11.953 |
Trading Information
Northwest Biotherapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | -0.129225 |
| 52-Week Change | -12.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.26 EUR |
| 52 Week Low | 0.42 EUR |
| 50-Day Moving Average | 0.53 EUR |
| 200-Day Moving Average | 0.66 EUR |
NBYB.SG Share Statistics
| Avg. Volume (3 month) | 2.05K EUR |
| Avg. Daily Volume (10-Days) | 1.05K EUR |
| Shares Outstanding | 1.09B |
| Float | 1B |
| Short Ratio | N/A |
| % Held by Insiders | 11.18% |
| % Held by Institutions | 0.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3141.61% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -133.52% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.16M EUR |
| Revenue Per Share (ttm) | 0.002 EUR |
| Quarterly Revenue Growth (yoy) | 118.39% |
| Gross Profit (ttm) | -33828000 EUR |
| EBITDA | -66372000 EUR |
| Net Income Avi to Common (ttm) | -101865000 EUR |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.19M EUR |
| Total Cash Per Share (mrq) | 0.006 EUR |
| Total Debt (mrq) | 31.36M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.212 |
| Book Value Per Share (mrq) | -0.052 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -51047000 EUR |
| Levered Free Cash Flow (ttm) | -117794872 EUR |
Profile of Northwest Biotherapeutics, Inc.
| Country | Germany |
| State | MD |
| City | Bethesda |
| Address | 4800 Montgomery Lane |
| ZIP | 20814 |
| Phone | 240 497 9024 |
| Website | https://www.nwbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 22 |
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Q&A For Northwest Biotherapeutics, Inc. Stock
What is a current NBYB.SG stock price?
Northwest Biotherapeutics, Inc. NBYB.SG stock price today per share is 0.44 EUR.
How to purchase Northwest Biotherapeutics, Inc. stock?
You can buy NBYB.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Northwest Biotherapeutics, Inc.?
The stock symbol or ticker of Northwest Biotherapeutics, Inc. is NBYB.SG.
Which industry does the Northwest Biotherapeutics, Inc. company belong to?
The Northwest Biotherapeutics, Inc. industry is Biotechnology.
How many shares does Northwest Biotherapeutics, Inc. have in circulation?
The max supply of Northwest Biotherapeutics, Inc. shares is 1.4B.
What is Northwest Biotherapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Northwest Biotherapeutics, Inc. PE Ratio is now.
What was Northwest Biotherapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Northwest Biotherapeutics, Inc. EPS is -0.07 EUR over the trailing 12 months.
Which sector does the Northwest Biotherapeutics, Inc. company belong to?
The Northwest Biotherapeutics, Inc. sector is Healthcare.